China Pharma Holdings, Inc.CPHINYSE
Loading
Year-over-year net income growth rate
Percentile
P44
Within normal range
vs 3Y Ago
-2.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -23.30% |
| Q2 2025 | 32.74% |
| Q1 2025 | 35.84% |
| Q4 2024 | -9.53% |
| Q3 2024 | 22.27% |
| Q2 2024 | -50.45% |
| Q1 2024 | 22.42% |
| Q4 2023 | -58.46% |
| Q3 2023 | -31.12% |
| Q2 2023 | -24.59% |
| Q1 2023 | 62.35% |
| Q4 2022 | -59.87% |
| Q3 2022 | 10.99% |
| Q2 2022 | 13.71% |
| Q1 2022 | -4.97% |
| Q4 2021 | -18.64% |
| Q3 2021 | -0.23% |
| Q2 2021 | -7.48% |
| Q1 2021 | 36.53% |
| Q4 2020 | -19.72% |
| Q3 2020 | -7836.89% |
| Q2 2020 | 101.98% |
| Q1 2020 | 96.47% |
| Q4 2019 | -2574.25% |
| Q3 2019 | 16.36% |
| Q2 2019 | -100.63% |
| Q1 2019 | 94.50% |
| Q4 2018 | -308.94% |
| Q3 2018 | -84.17% |
| Q2 2018 | -243.48% |
| Q1 2018 | 97.88% |
| Q4 2017 | -529.82% |
| Q3 2017 | 4.04% |
| Q2 2017 | -136.62% |
| Q1 2017 | 71.78% |
| Q4 2016 | -95.78% |
| Q3 2016 | 28.69% |
| Q2 2016 | -58.01% |
| Q1 2016 | -286.53% |
| Q4 2015 | -71.60% |